James Foundation Board & Other Organizations

We all have a story to share and a desire to live in a cancer-free world. Through that personal mission and shared vision, the OSUCCC – James Foundation Board helps tackle our collective responsibility to achieve our ambitious fundraising goal of $500 million toward the Ohio State’s “But for Ohio State” campaign.

The continued support, combined with the extraordinary efforts of our cancer experts, is essential to helping us achieve strategic, programmatic and financial growth that will benefit cancer patients and families for years to come.

James Foundation Board Mission

To provide financial assistance to benefit the OSUCCC – James and its related activities (Code of Regulations, Article II).

Board Composition (per Code of Regulations)

  • Not less than 16 members; up to three are designated
  • Service term equals three years
  • All members have the right to vote and are counted as part of the quorum

Board Qualifications

  • Personal connection to and passion for the cancer cause
  • Commitment to The James and its mission
  • Enhance the diversity of the board
  • Bring added expertise to the board
  • Track record of community involvement
  • Leadership
  • Dedication
  • Embrace philanthropy and volunteerism
  • Capable of and willing to financially support annual fund, campaigns and special events

Executive Committee Members

Lisa Hinson, Chair
President, Hinson LTD Public Relations

Michael Schoen, Vice Chair    
Managing Director, Latin America & Caribbean Dept. Capital Markets, Scotiabank

Bill Carter, Vice Chair
Executive VP & CFO, Momentive Performance Materials Holdings LLC

Eileen Halter, Treasurer
President, CEO and Chairman of the Board, Schnipke Engraving Company, Inc.

Nick Coe, Secretary
CEO, Bath and Body Works

Cindy Hilsheimer, Governance & Nominating Chair
Managing Principal, BeecherHill

Peter Z. Horvath, Executive Committee Member At-Large
Chairman of the Board and CEO, Mission Essential Personnel, LLC

Diane Nye, Executive Committee Member At-Large    

Charles E. Ruma, Executive Committee Member At-Large
President, Virginia Homes

James Foundation Board

Daniel B. Benhase

Janis B. Bloch    

Jeri B. Block
Block Realty

Kenton R. Bowen
Chairman and CEO, ContactUS, Inc.

Michael A. Caligiuri, MD
Director, The Ohio State University Comprehensive Cancer Center
CEO, James Cancer Hospital and Solove Research Institute

Don Casey, Jr.     
CEO, Medical Segment, Cardinal Health

Jeg Coughlin, Jr.
NHRA Driver, JEGS High Performance Inc.

Dale Darnell

William Farrar, MD
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Chair in Surgical Oncology
Director, Medical Affairs, OSUCCC - James
Director, OSU's Stefanie Spielman Comprehensive Breast Center
Professor of Surgery
Dr. Arthur G. and Mildred C. James - Richard J. Solove Chair in Surgical Oncology

Steven Gabbe, MD
Senior VP For Health Sciences; CEO,The Ohio State University Wexner Medical Center

Sarah Benson Hatcher
Director, Marketing and Public Relations, CASTO

Francie Henry
Executive VP, Fifth Third Bank

Robin V. Holderman
Chief Asset and Development Officer, Columbus Regional Airport Authority

Irene J. Levine    

Marnette Perry
Senior Vice President, Strategic Initiatives and Operations, The Kroger Company

Richard R. Porter
President, Te-Co

Jon J. Ricker
Executive Vice President, Cyber & Technology Solutions, Mission Essential Personnel, LLC

Daniel H. Rosenthal
President, Milestone Aviation Group LLC

Mark C. Ryan

David E. Schuller, MD
Executive Director, Health System Administration
VP, Medical Center Expansion and Outreach
Medical Director, OSU Medical Center Development
CEO Emeritus, James Cancer Hospital and Solove Research Institute
Director Emeritus, Comprehensive Cancer Center

Judith E. Tuckerman
Secretary, Tuckerman Development

Dennis E. Welch
Executive VP & Chief External Officer, American Electric Power (AEP)

Robert White, Jr.
President, The Daimler Group, Inc.

Alec Wightman
Partner, Baker & Hostetler, Counselors-at-Law

Rita Jean Wolfe
Corporate Director of Civic Affairs, Dispatch Printing Company

Legal Liaison
Dustin Frazier
Associate, Baker & Hostetler, Counselors-at-Law

Emeritus Member
Cheryl Krueger
CEO, Krueger&Co Consulting, Inc.

As of March 13, 2015

Latest News

New Clinical Trial Aims to Reprogram Cells to Attack a Specific Relapsed Blood Cancer

An upcoming clinical trial at The James aims to reprogram a patient’s immune cells to attack a specific relapsed blood cancer, called multiple myeloma. The idea is to “super-charge” the patient’s immune...

Read More

NCCN Publishes New Guidelines for Smoking Cessation, Effort Led by Ohio State Oncologist

To meet the needs of patients who are smokers at the time of a cancer diagnosis, the National Comprehensive Cancer Network has published smoking cessation guidelines. Ohio State's Peter Shields, MD...

Read More

Molecules in Prostate Tumors Might Predict Whether RT Can Help Prevent Recurrence

A new study has identified a group of molecules in prostate-cancer cells that doctors might one day use to distinguish which patients should be treated with radiation therapy if rising PSA levels...

Read More